EP0755262A4 - Composition for the treatment of lung disease - Google Patents
Composition for the treatment of lung diseaseInfo
- Publication number
- EP0755262A4 EP0755262A4 EP95913618A EP95913618A EP0755262A4 EP 0755262 A4 EP0755262 A4 EP 0755262A4 EP 95913618 A EP95913618 A EP 95913618A EP 95913618 A EP95913618 A EP 95913618A EP 0755262 A4 EP0755262 A4 EP 0755262A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- treatment
- composition
- lung disease
- lung
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21242094A | 1994-03-11 | 1994-03-11 | |
US212420 | 1994-03-11 | ||
PCT/US1995/002938 WO1995024207A1 (en) | 1994-03-11 | 1995-03-07 | Composition for the treatment of lung disease |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0755262A1 EP0755262A1 (en) | 1997-01-29 |
EP0755262A4 true EP0755262A4 (en) | 1997-05-07 |
Family
ID=22790936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95913618A Withdrawn EP0755262A4 (en) | 1994-03-11 | 1995-03-07 | Composition for the treatment of lung disease |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0755262A4 (en) |
JP (1) | JPH09510212A (en) |
AU (1) | AU686780B2 (en) |
CA (1) | CA2184385A1 (en) |
WO (1) | WO1995024207A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101314461B1 (en) * | 2004-05-12 | 2013-10-07 | 더 브리검 앤드 우먼즈 하스피털, 인크. | Use of gelsolin to treat infections |
HUE056086T2 (en) | 2006-03-15 | 2022-01-28 | Brigham & Womens Hospital Inc | Use of gelsolin to diagnose and treat inflammatory diseases |
KR20210018323A (en) | 2018-06-06 | 2021-02-17 | 매사추세츠 인스티튜트 오브 테크놀로지 | Circular RNA for translation in eukaryotic cells |
AU2020280105A1 (en) | 2019-05-22 | 2022-01-20 | Massachusetts Institute Of Technology | Circular RNA compositions and methods |
EP4289951A3 (en) | 2019-12-04 | 2024-03-13 | Orna Therapeutics, Inc. | Circular rna compositions and methods |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991015770A1 (en) * | 1990-04-11 | 1991-10-17 | The General Hospital Corporation | Therapeutic uses of actin-binding compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ228600A (en) * | 1988-04-11 | 1992-02-25 | Merck & Co Inc | 1-(benzylaminocarbonyl)-4-phenoxy-azetidin-2-one derivatives |
IL99658A0 (en) * | 1990-10-15 | 1992-08-18 | Merck & Co Inc | Substituted azetidinones and pharmaceutical compositions containing them |
US5276139A (en) * | 1991-08-26 | 1994-01-04 | Merck & Co., Inc. | Haptens useful in evaluating inhibition of PNN elastase by N-substituted azetidinones |
-
1995
- 1995-03-07 WO PCT/US1995/002938 patent/WO1995024207A1/en not_active Application Discontinuation
- 1995-03-07 EP EP95913618A patent/EP0755262A4/en not_active Withdrawn
- 1995-03-07 JP JP7523641A patent/JPH09510212A/en active Pending
- 1995-03-07 AU AU20994/95A patent/AU686780B2/en not_active Ceased
- 1995-03-07 CA CA002184385A patent/CA2184385A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991015770A1 (en) * | 1990-04-11 | 1991-10-17 | The General Hospital Corporation | Therapeutic uses of actin-binding compounds |
Also Published As
Publication number | Publication date |
---|---|
WO1995024207A1 (en) | 1995-09-14 |
JPH09510212A (en) | 1997-10-14 |
AU2099495A (en) | 1995-09-25 |
EP0755262A1 (en) | 1997-01-29 |
AU686780B2 (en) | 1998-02-12 |
CA2184385A1 (en) | 1995-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1000697A1 (en) | Use of droloxifene for the treatment of cardiovascular diseases | |
GB9421709D0 (en) | Therapeutic compounds | |
ZA955644B (en) | Therapeutic compounds | |
ZA953256B (en) | Skin treatment composition | |
EP0777474A4 (en) | Methods for the treatment of inflammatory joint disease | |
PL311916A1 (en) | Pharmaceutic composition for treating skin diseases | |
ZA954984B (en) | Compositions and methods for the treatment of tumors | |
IL121096A0 (en) | Pharmaceutical compositions for the treatment of liver disease | |
GB9414399D0 (en) | Medical nebuliser | |
GB9405021D0 (en) | Skin treatment composition | |
EP0755262A4 (en) | Composition for the treatment of lung disease | |
EP0806962A4 (en) | Methods for the treatment of acid aspiration-induced acute lung injury | |
IL113057A0 (en) | Compositions for the treatment of dandruff | |
GB9510162D0 (en) | Compositions for the treatment of skin conditions | |
EP0724842A3 (en) | Preparation for the treatment of obesity | |
HUP0000569A3 (en) | Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states | |
ZA952120B (en) | Skin treatment composition | |
AU6097394A (en) | Method for the treatment of respiratory disease | |
ZA986324B (en) | Composition for the treatment of immunodeficiency disease | |
HUP0000570A3 (en) | Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states | |
HU9700079D0 (en) | Topical compositions for the treatment of skin disease | |
HUP0000476A3 (en) | Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states | |
IL114089A0 (en) | Methods for the preparation of alpha-chloroacetoacetanilide compounds | |
GB9407105D0 (en) | Liver disease treatment | |
IL111296A0 (en) | Diagnosis of lung condition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19961011 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19970319 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE |
|
17Q | First examination report despatched |
Effective date: 19971126 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19990128 |